Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study
Jun Te Hsu*, Puo Hsien Le, Chang Fu Kuo, Meng Jiun Chiou, Chia Jung Kuo, Tsung Hsing Chen, Chun Jung Lin, Jen Shi Chen, Huang Pin Yu, Chun Nan Yeh, Yi Yin Jan, Ta Sen Yeh
Research output: Contribution to journal › Journal Article › peer-review
9Scopus
citations
Fingerprint
Dive into the research topics of 'Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study'. Together they form a unique fingerprint.